VERV Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 21.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $18,818.66

Verve Therapeutics Insider Trading History Chart

Verve Therapeutics Share Price & Price History

^$6.58

▼ -0.3 (-4.36%)

As of 04/24/2024 01:00 AM ET

Days: 30 | 90 | 365

Did You Get Your Free Bitcoin Yet?

From Crypto Swap Profits | Ad

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

Verve Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/2/2024	Joan Nickerson	Insider	Sell	1,514	$8.24	$12,475.36	8,659
11/29/2023	Allison Dorval	CFO	Sell	554	$11.45	$6,343.30	4,060
12/1/2022	Andrew Bellinger	CMO	Sell	865	$22.95	$19,851.75	6,629
11/29/2022	Allison Dorval	CFO	Sell	554	$22.10	$12,243.40	2,186
11/4/2022	2017 Gp L.L.C. Gv	Major Shareholder	Sell	97,166	$31.14	$3,025,749.24
11/3/2022	Krishna Yeshwant	Director	Sell	49,568	$32.79	$1,625,334.72	4,308,630
11/2/2022	2017 Gp L.L.C. Gv	Major Shareholder	Sell	57,303	$35.94	$2,059,469.82
10/31/2022	2017 Gp L.L.C. Gv	Major Shareholder	Sell	107,393	$38.64	$4,149,665.52
10/31/2022	Krishna Yeshwant	Director	Sell	53,696	$38.64	$2,074,813.44	4,418,813
10/28/2022	Andrew Bellinger	CMO	Sell	10,000	$39.90	$399,000.00	6,629
10/3/2022	Sekar Kathiresan	CEO	Sell	50,000	$33.65	$1,682,500.00	317,839
9/23/2022	Andrew Bellinger	CMO	Sell	60,000	$35.34	$2,120,400.00	6,629
8/10/2022	Sekar Kathiresan	CEO	Sell	50,000	$29.90	$1,495,000.00	317,839
7/20/2022	Andrew Bellinger	CMO	Sell	20,000	$34.90	$698,000.00	6,629
7/19/2022	Sekar Kathiresan	CEO	Sell	50,000	$29.90	$1,495,000.00	317,839
7/13/2022	Andrew Bellinger	CMO	Sell	10,000	$24.90	$249,000.00	6,629
7/12/2022	Fmr Llc	Insider	Sell	163,000	$20.78	$3,387,140.00	570,729
7/1/2022	Fmr Llc	Insider	Sell	38,775	$15.66	$607,216.50	773,729
6/29/2022	Fmr Llc	Insider	Sell	34,409	$15.59	$536,436.31	791,314
5/12/2022	Burt A. Adelman	Director	Buy	10,000	$12.15	$121,500.00	18,700
3/15/2022	Burt A. Adelman	Director	Buy	4,000	$21.38	$85,520.00
3/9/2022	Fmr Llc	Insider	Sell	3,971	$29.01	$115,198.71
2/9/2022	Fmr Llc	Insider	Sell	13,190	$29.46	$388,577.40
2/1/2022	Fmr Llc	Insider	Sell	35,574	$29.04	$1,033,068.96
1/26/2022	Fmr Llc	Insider	Sell	149,853	$31.23	$4,679,909.19
1/4/2022	Sekar Kathiresan	CEO	Sell	1,870	$39.90	$74,613.00
12/28/2021	Sekar Kathiresan	CEO	Sell	6,693	$39.90	$267,050.70
12/22/2021	Andrew Bellinger	Insider	Sell	15,000	$38.70	$580,500.00
12/22/2021	Sekar Kathiresan	CEO	Sell	57,000	$38.71	$2,206,470.00
12/2/2021	Andrew D. Ashe	Insider	Buy	4,000	$32.10	$128,400.00
12/2/2021	Burt A. Adelman	Director	Buy	4,700	$31.34	$147,298.00

Did You Get Your Free Bitcoin Yet?

From Crypto Swap Profits | Ad

>> Register right here

SEC Filings (Institutional Ownership Changes) for Verve Therapeutics (NASDAQ:VERV)

97.11% of Verve Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Verve Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/19/2024	Sumitomo Mitsui Trust Holdings Inc.	2,592,198	$34.42M	0.0%	+8.1%	3.100%
4/10/2024	Green Alpha Advisors LLC	24,940	$0.33M	0.2%	+11.5%	0.030%
3/28/2024	Newbridge Financial Services Group Inc.	2,182	$30K	0.0%	N/A	0.003%
3/27/2024	Nomura Holdings Inc.	19,076	$0.27M	0.0%	+5.0%	0.023%
3/22/2024	PNC Financial Services Group Inc.	2,094	$29K	0.0%	N/A	0.003%
3/5/2024	Wellington Management Group LLP	157,241	$2.19M	0.0%	-80.2%	0.247%
3/5/2024	PBCay One RSC Ltd	6,864	$96K	0.0%	N/A	0.011%
2/22/2024	Sierra Summit Advisors LLC	12,709	$0.18M	0.1%	N/A	0.020%
2/14/2024	Bellevue Group AG	39,000	$0.54M	0.0%	N/A	0.061%
2/13/2024	Rafferty Asset Management LLC	351,904	$4.91M	0.0%	+10.0%	0.552%
2/13/2024	NEOS Investment Management LLC	13,787	$0.19M	0.0%	N/A	0.022%
2/12/2024	Capstone Investment Advisors LLC	10,173	$0.14M	0.0%	N/A	0.016%
2/12/2024	Fiduciary Trust Co	10,000	$0.14M	0.0%	N/A	0.016%
2/9/2024	Quest Partners LLC	2,405	$34K	0.0%	N/A	0.004%
2/8/2024	Nikko Asset Management Americas Inc.	2,397,604	$33.33M	0.3%	+11.7%	3.761%
2/8/2024	Mitsubishi UFJ Asset Management Co. Ltd.	19,884	$0.26M	0.0%	+20.7%	0.031%
2/7/2024	E Fund Management Co. Ltd.	16,378	$0.23M	0.0%	+13.8%	0.026%
2/6/2024	Charles Schwab Investment Management Inc.	369,670	$5.15M	0.0%	+1.8%	0.580%
2/6/2024	Vestmark Advisory Solutions Inc.	113,324	$1.58M	0.1%	N/A	0.178%
2/6/2024	Swiss National Bank	108,500	$1.51M	0.0%	+13.9%	0.170%
2/1/2024	New York State Common Retirement Fund	21,651	$0.30M	0.0%	-6.0%	0.034%
1/31/2024	Federated Hermes Inc.	3,980,372	$55.49M	0.1%	+57.2%	6.244%
1/31/2024	Daiwa Securities Group Inc.	6,772	$94K	0.0%	+35.1%	0.011%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	12,861	$0.18M	0.0%	+80.8%	0.020%
1/30/2024	SVB Wealth LLC	12,187	$0.17M	0.0%	N/A	0.019%
1/30/2024	Sumitomo Mitsui Trust Holdings Inc.	2,397,604	$33.42M	0.0%	+11.7%	3.761%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	112,761	$1.57M	0.0%	-46.8%	0.177%
1/24/2024	DekaBank Deutsche Girozentrale	26,690	$0.37M	0.0%	-46.6%	0.042%
1/24/2024	International Assets Investment Management LLC	6,970	$97K	0.0%	N/A	0.011%
1/24/2024	Arizona State Retirement System	15,360	$0.21M	0.0%	+24.4%	0.024%
1/24/2024	China Universal Asset Management Co. Ltd.	8,815	$0.12M	0.0%	+437.2%	0.014%
1/17/2024	ARK Investment Management LLC	7,025,116	$97.93M	0.6%	+35.1%	11.020%
1/12/2024	SG Americas Securities LLC	50,802	$0.71M	0.0%	+171.5%	0.080%
1/5/2024	Green Alpha Advisors LLC	22,366	$0.31M	0.2%	-9.2%	0.035%
12/18/2023	Vanguard Group Inc.	4,832,968	$64.09M	0.0%	+18.1%	7.581%
12/1/2023	Wellington Management Group LLP	792,526	$10.51M	0.0%	-18.8%	1.243%
11/15/2023	GSA Capital Partners LLP	56,895	$0.75M	0.1%	N/A	0.089%
11/15/2023	Redmile Group LLC	809,777	$10.74M	0.5%	-23.7%	1.270%
11/14/2023	Avidity Partners Management LP	285,334	$3.78M	0.2%	-67.5%	0.448%
11/14/2023	Profund Advisors LLC	47,093	$0.62M	0.0%	+8.0%	0.074%
11/13/2023	Federated Hermes Inc.	2,532,369	$33.58M	0.1%	+5.4%	3.972%
11/13/2023	FMR LLC	6,577,562	$87.22M	0.0%	+8.8%	10.318%
11/13/2023	Rafferty Asset Management LLC	319,800	$4.24M	0.0%	+14.2%	0.502%
11/13/2023	E Fund Management Co. Ltd.	14,397	$0.19M	0.0%	+11.6%	0.023%
11/9/2023	Citigroup Inc.	120,669	$1.60M	0.0%	+34.8%	0.189%
11/8/2023	Charles Schwab Investment Management Inc.	363,044	$4.81M	0.0%	+8.2%	0.570%
11/8/2023	Swiss National Bank	95,300	$1.26M	0.0%	+8.8%	0.150%
11/7/2023	Merit Financial Group LLC	11,416	$0.15M	0.0%	N/A	0.018%
11/7/2023	Virtus ETF Advisers LLC	5,782	$77K	0.0%	-9.1%	0.009%
11/7/2023	Barclays PLC	144,218	$1.91M	0.0%	+18.9%	0.226%
11/7/2023	Jump Financial LLC	26,913	$0.36M	0.0%	N/A	0.042%
11/7/2023	Arizona State Retirement System	12,343	$0.16M	0.0%	+9.3%	0.019%
11/7/2023	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	16,479	$0.22M	0.0%	+5.6%	0.026%
11/2/2023	Principal Financial Group Inc.	16,847	$0.22M	0.0%	+18.0%	0.026%
10/31/2023	Teacher Retirement System of Texas	12,058	$0.16M	0.0%	+10.8%	0.019%
10/30/2023	Sumitomo Mitsui Trust Holdings Inc.	2,147,243	$28.47M	0.0%	-1.8%	3.370%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	212,104	$2.81M	0.0%	+8.9%	0.333%
10/18/2023	ARK Investment Management LLC	5,200,567	$68.96M	0.5%	+1.0%	8.162%
10/13/2023	SG Americas Securities LLC	18,715	$0.25M	0.0%	N/A	0.029%
10/10/2023	Green Alpha Advisors LLC	24,625	$0.33M	0.3%	N/A	0.039%
9/21/2023	Barclays PLC	121,320	$2.28M	0.0%	+11.5%	0.190%
8/14/2023	Casdin Capital LLC	2,360,571	$44.26M	3.9%	+11.3%	3.705%
8/14/2023	Jefferies Financial Group Inc.	177,716	$3.33M	0.0%	-33.5%	0.279%
8/11/2023	E Fund Management Co. Ltd.	12,898	$0.24M	0.0%	-13.6%	0.021%
8/11/2023	JPMorgan Chase & Co.	1,838,986	$34.48M	0.0%	-3.6%	2.970%
8/11/2023	Penserra Capital Management LLC	7,194	$0.13M	0.0%	+18.9%	0.012%
8/11/2023	ExodusPoint Capital Management LP	190,071	$3.56M	0.0%	-27.9%	0.307%
8/10/2023	ProShare Advisors LLC	10,605	$0.20M	0.0%	N/A	0.017%
8/10/2023	Profund Advisors LLC	43,602	$0.82M	0.0%	-10.5%	0.070%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	194,827	$3.65M	0.0%	+15.3%	0.315%
8/10/2023	Citigroup Inc.	89,543	$1.68M	0.0%	-81.9%	0.145%
8/9/2023	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	15,608	$0.29M	0.0%	N/A	0.025%
8/8/2023	Rhumbline Advisers	79,383	$1.49M	0.0%	+10.6%	0.128%
8/4/2023	American International Group Inc.	24,418	$0.46M	0.0%	+8.2%	0.039%
8/3/2023	Barclays PLC	121,320	$2.28M	0.0%	+11.5%	0.196%
8/3/2023	Bank of New York Mellon Corp	186,785	$3.50M	0.0%	+9.1%	0.302%
8/1/2023	Arizona State Retirement System	11,289	$0.21M	0.0%	N/A	0.018%
7/31/2023	Daiwa Securities Group Inc.	5,013	$94K	0.0%	+2,168.3%	0.008%
7/31/2023	Sumitomo Mitsui Trust Holdings Inc.	2,185,857	$40.99M	0.0%	+36.8%	3.530%
7/25/2023	DekaBank Deutsche Girozentrale	50,000	$0.94M	0.0%	+117.4%	0.081%
7/10/2023	ARK Investment Management LLC	5,150,851	$96.58M	0.6%	+14.9%	8.319%
5/15/2023	Hood River Capital Management LLC	344,776	$4.97M	0.2%	+2.8%	0.557%
5/12/2023	Profund Advisors LLC	48,727	$0.70M	0.0%	N/A	0.079%
5/11/2023	FMR LLC	6,826,817	$98.44M	0.0%	-1.1%	11.025%
5/11/2023	ExodusPoint Capital Management LP	263,620	$3.80M	0.0%	+291.5%	0.426%
5/11/2023	Citigroup Inc.	494,019	$7.12M	0.0%	+198.2%	0.798%
5/11/2023	E Fund Management Co. Ltd.	14,936	$0.22M	0.0%	-23.5%	0.024%
5/8/2023	Federated Hermes Inc.	2,402,640	$34.65M	0.1%	+15.6%	3.880%
5/4/2023	Barclays PLC	108,846	$1.57M	0.0%	-46.2%	0.176%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	168,946	$2.44M	0.0%	+7.8%	0.273%
5/3/2023	Nikko Asset Management Americas Inc.	1,597,994	$22.37M	0.3%	+30.1%	2.584%
5/2/2023	Amalgamated Bank	5,096	$73K	0.0%	-18.6%	0.008%
4/27/2023	Sumitomo Mitsui Trust Holdings Inc.	1,597,994	$23.04M	0.0%	+30.1%	2.584%
4/17/2023	ARK Investment Management LLC	4,482,091	$64.63M	0.4%	+2.7%	7.249%
2/15/2023	Avidity Partners Management LP	1,565,000	$30.28M	0.7%	+50.1%	2.541%
2/15/2023	Jefferies Financial Group Inc.	275,713	$5.34M	0.0%	N/A	0.448%
2/13/2023	Nikko Asset Management Americas Inc.	1,228,447	$23.77M	0.3%	+58.4%	1.994%
2/13/2023	ExodusPoint Capital Management LP	67,344	$1.30M	0.0%	N/A	0.109%
2/13/2023	JPMorgan Chase & Co.	1,788,462	$34.61M	0.0%	-6.8%	2.903%
2/13/2023	Artal Group S.A.	300,000	$5.81M	0.3%	-25.0%	0.487%

Data available starting January 2016

Verve Therapeutics, Inc., a clinical stage genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases in the United States. The company's lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver; and VERVE-102, a product candidate that targets the PCSK9 gene for the treatment of HeFH. It engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with Beam Therapeutics Inc.; a development and option agreement with Acuitas Therapeutics, Inc.; and a Cas9 license agreement with The Broad Institute and the President and Fellows of Harvard College. The company was formerly known as Endcadia, Inc. and changed its name to Verve Therapeutics, Inc. in January 2019. Verve Therapeutics, Inc. was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $6.58

$6.53

$6.92

50 Day Range

MA: $11.92

$6.58

$17.96

52 Week Range

Now: $6.58

$6.42

$21.42

Volume

1,003,755 shs

Average Volume

1,563,579 shs

Market Capitalization

$550.22 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.7

Who are the company insiders with the largest holdings of Verve Therapeutics?: Verve Therapeutics' top insider investors include:
Krishna Yeshwant (Director)
Fmr Llc (Insider)
Sekar Kathiresan (CEO)
Burt A Adelman (Director)
Joan Nickerson (Insider)
Andrew Bellinger (CMO)
Allison Dorval (CFO)
2017 Gp LLC Gv (Major Shareholder)
Learn More about top insider investors at Verve Therapeutics.
Who are the major institutional investors of Verve Therapeutics?: Verve Therapeutics' top institutional investors include:
Sumitomo Mitsui Trust Holdings Inc. — 3.10%
Green Alpha Advisors LLC — 0.03%
Learn More about top institutional investors of Verve Therapeutics stock.
Which major investors are buying Verve Therapeutics stock?: Within the last quarter, VERV stock was purchased by institutional investors including:
Sumitomo Mitsui Trust Holdings Inc.
Green Alpha Advisors LLC